Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2009-10-06
2011-12-20
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S252160, C514S253040, C514S300000, C544S127000, C544S254000, C544S362000, C546S117000
Reexamination Certificate
active
08080547
ABSTRACT:
The invention relates to the triazolopyridine carboxamide derivative and trizolopyrimidine carboxamide derivative of general Formula (I):Wherein X, R1and R2are as defined herein. The invention further relates to preparation methods and therapeutic use thereof.
REFERENCES:
patent: 6995184 (2006-02-01), Barth et al.
patent: WO 02/055083 (2002-07-01), None
patent: WO 2004/035550 (2004-04-01), None
patent: WO 2005/073199 (2005-08-01), None
patent: WO 2006/138657 (2006-12-01), None
patent: WO 2007/045392 (2007-04-01), None
Fox et al. Expert Opin.Investig.Drugs, vol. 14, p. 695-703 (2005).
Teare et al.Expert Opin.Investig.Drugs, vol. 14, p. 859-869 (2005).
Cravatt et al. Current Opinion in Chemical Biology, vol. 7, p. 469-475 (2003).
Magrioti et al. Bioorganic & Medicinal Chemistry Letters, vol. 18, p. 5424-5427 (2008).
Dinh, T. P., et. al., Brain Monoglyceride Lipase Participating in Endocannabinoid Inactivation, PNAS, (2002), vol. 99, No. 16, pp. 10819-10824.
Dinh, T. P., et. al., RNA Interference Suggests a Primary Role for Monoacylglycerol Lipase in the Degradation of the Endocannabinoid 2-Arachidonoylglycerol, Molecular Pharmacology, (2004), vol. 66, No. 5, pp. 1260-1264.
Fowler, C. J., et. al., Ibuprofen inhibits Rat Brain Deamidation of Anandamide at Pharmacologically Relevant Concentrations. Mode of Inhibition and Structure-Activity Relationship, The Journal of Pharmacology and Experimental Therapeutics, vol. 283, No. 2, pp. 729-734, (1997).
Karlsson, M., et. al., cDNA Cloning, Tissue Distribution, and identification of Catalytic Triad of Monoglyceride Lipase, The Journal of Biological Chemistry, vol. 272, No. 43, pp. 27218-27223, (1997).
Kondo, S., et. al., 2-Arachidonoylglycerol, an Endogenous Cannabinoid Receptor Agonist: Identification as One of the Major Species of Monoacylglycerols in Various Rat Tissues, and Evidence for its Generation Through Ca2+-Dependent and -Independent Mechanisms, FEBS Letters, vol. 429, (1998), pp. 152-156.
Omeir, R. L., et. al., Arachidonoyl Ethanolamide-[1,2-14c] as a Substrate for Anandamide Amidase, Life Sciences, vol. 56, No. 23/24, pp. 1999-2005, (1995).
Saario, S. M., et. al., Monoglyceride Lipase-Like Enzymatic Activity is Responsible for Hydrolysis of 12-Arachidonoylglycerol in Rat Cerebellar Membranes, Biochemical Pharmacology, vol. 67, (2004), pp. 1381-1387.
Savinainen, J. R. , et. al. , Despite Substantial Degradtion, 2-Arachidonoylglycerol is a Potent Full Efficacy Agonist Mediating CB1 Receptor-Dependent G-Protein Activation in Rat Cerebellar Membranes, British Journal of Pharmacology, (2001), vol. 134, pp. 664-672.
Sugiura, T., et. al., Biochemistry, Pharmacology and Physiology of 2-Arachidonoylglycerol, an Endogenous Cannabinoid Receptor Ligand , Progress in Lipid Research, vol. 45. (2006) pp. 405-446.
Sugiura, T., et. al., Evidence That 2-Arachidonoylglycerol but Not N-Palmitoylethanolamine or Anandamide is the Physiological Ligand for the Cannabinoid CB2 Receptor, The Journal of Biological Chemistry, vol. 275, No. 1, pp. 605-612, (2000).
Sugiura, T., et. al., Evidence That the Cannabinoid CB1 Receptor is a 2-Arachidonoylglycerol Receptor, The Journal of Biological Chemistry, vol. 274, No. 5, pp. 2794-2801, (1999).
Ueda, N., et. al., The Fatty Acid Amide Hydrolase (FAAH), Chemistry and Physics of Lipids, vol. 108, (2000), pp. 107-121.
Rice. K. D., et. al., Dibasic Inhibitors of Human Mast Cell Tryptase. Part 1: Synthesis and Optimization of a Novel Class of Inhibitors, Bioorganic & Medicinal Chemistry Letters, vol. 10, (2000), pp. 2357-2360.
Vaughn, J. R., et. al., Triazolo and Imidiazopyridines, J. Am. Chem. Soc., (1949), pp. 1885-1887.
Ueda, et al.; “The fatty acid amide hydrolose (FAAH)”; Chemistry and Physics of Lipids (2000), 108, pp. 107-121.
Martin, et al.; “Cannabinoid Transmission and Pain Reception”, Neurobiology of Disease, 1998, 5, pp. 447-461.
Pionnelli, et al.; The Endocannabinoid System as a Target for Therapeutic Drugs; Trends in Pharmacological Sciences 2000, 21, pp. 218-224.
Van Sickle, et al.; “Cannabinoids Inhibit Emesis Through CB1 Receptors in the Brainstorm of the Ferret”; Gastroenterology 2001, 121, pp. 767-774.
Porter, et al; “The Endocannabinoid Nervous System; Unique Opportunities for Therapeutic Intervention”; Pharmacology and Therapetuics 2001, 90, pp. 45-60.
Smith, et al.; “Anandamide Induces Cardiovascular and Respiratory Reflexes via Vasosensory Nerves in the Anasthetized Rat”; British Journal of Pharmacology 2001, 134, pp. 655-663.
Consroe; “Brain Cannabinoid Systems as Targets for the Therapy of Neurological Disorders”; Neurobiology of Disease 1998, 5, pp. 534-551.
Salzet, et al.; “Comparative biology of the Endocannabinoid System”; European Journal of Biochemistry 2000, 267, pp. 4917-4927.
Petrocellis, et al.; “Endocannabinoids and Fatty Acid Amides in Cancer, Inflammation and Related Disorders”; Chemistry and Physics of Lipids 2000, 108, pp. 191-209.
Jaggar, et al.; “The Anti-Hyperalgesic Actions of the Cannabinoid Anandamide and the Putative CB2 Receptor Agonist Palmitoyethanolamide in Visceral and Somatic Inflammatory Pain”; Pain 1998, 76, pp. 189-199.
Alzzo, et al., “The Gastrointestinal Pharmacology of Cannabinoids”; Current Opinion in Pharmcology 2001, 1, pp. 597-603.
Mendelson, et al., “The Hypnotic Actions of the Fatty Acid Amide, Oleamide”; Neuropsychopharmacology 2001, 25, pp. S36-S39.
Even Luc
Hoornaert Christian
Bender Kelly L.
Bernhardt Emily
Sanofi-Aventis
LandOfFree
Triazolopyridine carboxamide derivatives and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Triazolopyridine carboxamide derivatives and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazolopyridine carboxamide derivatives and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4269442